Status:
UNKNOWN
Exacerbantes Study
Lead Sponsor:
Sociedad Española de Neumología y Cirugía Torácica
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
COPD Exacerbation
Eligibility:
All Genders
40+ years
Brief Summary
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is understood as a complex and heterogeneous syndrome, which requires an increasingly personalized approach. A new approach to AECO...
Detailed Description
Justification COPD exacerbations (AECOPD) are heterogeneous and complex in nature, demanding an increasingly personalized approach. Recently, the ANTES proposal was presented, a patient-centered appro...
Eligibility Criteria
Inclusion
- Men or women who request emergency care (primary care or hospital) due to acute worsening of respiratory symptoms (of any nature)
- Age 40 years or older.
- Smokers or ex-smokers of \> 10 pack-years
- Expiratory airflow limitation, documented by any of the following methods:
- Post bronchodilation FEV1/FVC \< 0.7, in a previous forced spirometry, or
- FEV1/FEV6 less than 0.73 on microspirometry performed during decompensation
Exclusion
- Patients with active neoplasia in the last 3 years.
- Associated pleural effusion susceptible to thoracentesis.
- Pneumothorax.
- Thoracic trauma.
- Impossibility of subsequent follow-up (3 months).
Key Trial Info
Start Date :
December 31 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06147206
Start Date
December 31 2023
End Date
March 31 2025
Last Update
November 27 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.